Literature DB >> 12077073

Serotonergic modulation of visceral sensation: upper gastrointestinal tract.

J Tack1, G Sarnelli.   

Abstract

Agents that modify serotonergic function have therapeutic potential for the treatment of visceral hypersensitivity, either through a direct effect on perception or through modulation of visceral tone or motility. Administration of selective serotonin reuptake inhibitors reduces oesophageal sensitivity to distension but not gastric sensitivity to distension. 5-HT ligands may also influence gastric mechanosensitivity by altering tone. Although the exact role of 5-HT receptors in the control of gastrointestinal functions remains unknown, 5-HT is generally considered to be the main candidate involved in the modulation of motor and sensory function from the gastrointestinal tract. Hence serotonergic modulation of upper gut sensitivity appears to be promising for the development of novel approaches to the treatment of functional disorders of the upper gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077073      PMCID: PMC1867718          DOI: 10.1136/gut.51.suppl_1.i77

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

Review 1.  Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.

Authors:  M D Gershon
Journal:  Aliment Pharmacol Ther       Date:  1999-05       Impact factor: 8.171

Review 2.  Visceral hypersensitivity: facts, speculations, and challenges.

Authors:  M Camilleri; B Coulie; J F Tack
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

3.  Visceral hyperalgesia revisited.

Authors:  F Cervero
Journal:  Lancet       Date:  2000-09-30       Impact factor: 79.321

4.  Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia.

Authors:  H Mertz; R Fass; A Kodner; F Yan-Go; S Fullerton; E A Mayer
Journal:  Am J Gastroenterol       Date:  1998-02       Impact factor: 10.864

5.  Spinal serotonin terminal system mediates antinociception.

Authors:  T L Yaksh; P R Wilson
Journal:  J Pharmacol Exp Ther       Date:  1979-03       Impact factor: 4.030

Review 6.  The enteric nervous system.

Authors:  M D Gershon
Journal:  Annu Rev Neurosci       Date:  1981       Impact factor: 12.449

Review 7.  The physiology and the pathophysiology of the gastric accommodation reflex in man.

Authors:  J Tack
Journal:  Verh K Acad Geneeskd Belg       Date:  2000

8.  Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia.

Authors:  J Tack; P Caenepeel; B Fischler; H Piessevaux; J Janssens
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

9.  A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia.

Authors:  N J Talley; S V Van Zanten; L R Saez; G Dukes; T Perschy; M Heath; C Kleoudis; A W Mangel
Journal:  Aliment Pharmacol Ther       Date:  2001-04       Impact factor: 8.171

10.  Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine.

Authors:  M D Gershon; G M Jonakait
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

View more
  21 in total

1.  Endocrine cells in the ileum of patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

2.  Factors related to abdominal pain in gastroparesis: contrast to patients with predominant nausea and vomiting.

Authors:  W L Hasler; L A Wilson; H P Parkman; K L Koch; T L Abell; L Nguyen; P J Pasricha; W J Snape; R W McCallum; I Sarosiek; G Farrugia; J Calles; L Lee; J Tonascia; A Unalp-Arida; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2013-02-17       Impact factor: 3.598

3.  Noncardiac chest pain: current treatment.

Authors:  Ron Schey; Autumn Villarreal; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-04

4.  Different faces of gastroparesis.

Authors:  Klaus Bielefeldt; Naeem Raza; Susan L Zickmund
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

Review 5.  Central serotonergic and noradrenergic receptors in functional dyspepsia.

Authors:  S O'Mahony; T G Dinan; P W Keeling; A S B Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

6.  Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women.

Authors:  J S Labus; E A Mayer; J Jarcho; L A Kilpatrick; T O C Kilkens; E A T Evers; W H Backes; R-J M Brummer; M A van Nieuwenhoven
Journal:  Gut       Date:  2011-03-14       Impact factor: 23.059

7.  Noncardiac Chest Pain.

Authors:  Wai-Man Wong; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08

8.  Role of cholecystokinin and central serotonergic receptors in functional dyspepsia.

Authors:  Andrew Seng Boon Chua; P W N Keeling; T G Dinan
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 9.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

10.  Genetic contribution to motility disorders of the upper gastrointestinal tract.

Authors:  Giovanni Sarnelli; Alessandra D'Alessandro; Marcella Pesce; Ilaria Palumbo; Rosario Cuomo
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.